+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopharmaceuticals Market Research Reports

Dengue Vaccine - Global Strategic Business Report - Product Thumbnail Image

Dengue Vaccine - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
Vaccine Adjuvants - Global Strategic Business Report - Product Thumbnail Image

Vaccine Adjuvants - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
Hollow Fiber Filtration - Global Strategic Business Report - Product Thumbnail Image

Hollow Fiber Filtration - Global Strategic Business Report

  • Report
  • November 2024
  • 244 Pages
  • Global
From
Biopharmaceuticals - Global Strategic Business Report - Product Thumbnail Image

Biopharmaceuticals - Global Strategic Business Report

  • Report
  • November 2024
  • 262 Pages
  • Global
From
Biosimilars - Global Strategic Business Report - Product Thumbnail Image

Biosimilars - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
H1N1 Vaccines - Global Strategic Business Report - Product Thumbnail Image

H1N1 Vaccines - Global Strategic Business Report

  • Report
  • November 2024
  • 268 Pages
  • Global
From
Pediatric Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Pediatric Drugs and Vaccines - Global Strategic Business Report

  • Report
  • November 2024
  • 292 Pages
  • Global
From
Bioengineered Protein Drugs - Global Strategic Business Report - Product Thumbnail Image

Bioengineered Protein Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
From
Monoclonal Antibodies - Global Strategic Business Report - Product Thumbnail Image

Monoclonal Antibodies - Global Strategic Business Report

  • Report
  • November 2024
  • 213 Pages
  • Global
From
Regenerative Medicine - Global Strategic Business Report - Product Thumbnail Image

Regenerative Medicine - Global Strategic Business Report

  • Report
  • November 2024
  • 198 Pages
  • Global
From
From
Biologics - Global Strategic Business Report - Product Thumbnail Image

Biologics - Global Strategic Business Report

  • Report
  • November 2024
  • 293 Pages
  • Global
From
Biological Drugs - Global Strategic Business Report - Product Thumbnail Image

Biological Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
Antibody Production - Global Strategic Business Report - Product Thumbnail Image

Antibody Production - Global Strategic Business Report

  • Report
  • November 2024
  • 103 Pages
  • Global
From
Vaccine Contract Manufacturing - Global Strategic Business Report - Product Thumbnail Image

Vaccine Contract Manufacturing - Global Strategic Business Report

  • Report
  • November 2024
  • 274 Pages
  • Global
From
Vaccine Delivery Devices - Global Strategic Business Report - Product Thumbnail Image

Vaccine Delivery Devices - Global Strategic Business Report

  • Report
  • November 2024
  • 93 Pages
  • Global
From
Microbiome Sequencing Services - Global Strategic Business Report - Product Thumbnail Image

Microbiome Sequencing Services - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
mRNA Platform - Global Strategic Business Report - Product Thumbnail Image

mRNA Platform - Global Strategic Business Report

  • Report
  • July 2024
  • 334 Pages
  • Global
From
Loading Indicator

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders. Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively. Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more